USNA
USANA Health Sciences, Inc.
$15.20
Stable Earnings Power
80%
P/Adj-EPS × Normalized Multiple
Strong
·
Conviction
Undervalued
Trading 76.7% below fair value
You pay
$15.20
Bear
$53.82
Fair
$65.35
Bull
$76.88
Bear
$53.82
+254.1%
$3.84 × 14x P/E
Fair
$65.35
+329.9%
$3.84 × 17x P/E
Bull
$76.88
+405.8%
$3.84 × 20x P/E
Adjust Assumptions
17.0x
3.84$
Key Value Driver
Normalized P/E multiple (17x base case)
Implied Market Multiple
4.0x
Analyst Consensus (External Reference)
Never blended into the bear/base/bull estimates above.
Average Target (8 analysts)
$35.00
Divergence from AlphaVal
87%
Summary
Applying a 17x P/E to adjusted EPS of $3.84, the base-case value is $65.35 per share.
Warnings
The company's reported profits differ from official accounting profits by 563%. Check what costs are being left out of the adjusted number.
Wall Street's average price target is $35.00 (from 8 analysts). Our estimate is 87% above the consensus -- consider that gap carefully.
This stock is 51% below its 52-week high, with weak or declining earnings. That combination often signals real trouble, even though the valuation below is based on other fundamentals.
Key Risks
- Growth DCF inappropriate — terminal value assumptions dominate
- EV/EBITDA misleading for regulated businesses where capex is mandated
- Regulatory risk is a fat tail not visible in normal multiples